The mevalonate pathway, a metabolic target in cancer therapy
B Guerra, C Recio, H Aranda-Tavío… - Frontiers in …, 2021 - frontiersin.org
A hallmark of cancer cells includes a metabolic reprograming that provides energy, the
essential building blocks, and signaling required to maintain survival, rapid growth …
essential building blocks, and signaling required to maintain survival, rapid growth …
The YAP/TAZ pathway in osteogenesis and bone sarcoma pathogenesis
YAP and TAZ are intracellular messengers communicating multiple interacting extracellular
biophysical and biochemical cues to the transcription apparatus in the nucleus and back to …
biophysical and biochemical cues to the transcription apparatus in the nucleus and back to …
[HTML][HTML] Simvastatin/hydrogel-loaded 3D-printed titanium alloy scaffolds suppress osteosarcoma via TF/NOX2-associated ferroptosis while repairing bone defects
Z **g, W Yuan, J Wang, R Ni, Y Qin, Z Mao, F Wei… - Bioactive materials, 2024 - Elsevier
Postoperative anatomical reconstruction and prevention of local recurrence after tumor
resection are two vital clinical challenges in osteosarcoma treatment. A three-dimensional …
resection are two vital clinical challenges in osteosarcoma treatment. A three-dimensional …
[HTML][HTML] Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms
AF Hassanabad - Translational Lung Cancer Research, 2019 - ncbi.nlm.nih.gov
Statins have been shown to inhibit cell proliferation in vitro and tumor growth in animal
models. Various studies have also shown a decreased cancer-specific mortality rate in …
models. Various studies have also shown a decreased cancer-specific mortality rate in …
Effects of statins on brain tumors: a review
Evidence from preclinical studies suggests that the competitive HMG-CoA reductase
(HMGCR) inhibitors universally known as' statins,'in addition to being powerful drugs that …
(HMGCR) inhibitors universally known as' statins,'in addition to being powerful drugs that …
Increased pro-apoptotic and anti-proliferative activities of simvastatin encapsulated PCL-PEG nanoparticles on human breast cancer adenocarcinoma cells
M Dadashpour, M Ganjibakhsh, H Mousazadeh… - Journal of Cluster …, 2023 - Springer
Recently, Simvastatin (SIM) is received notable attention due to its anti-cancer properties.
However, the lipophilicity feature of SIM restricted its application as a chemotherapy agent …
However, the lipophilicity feature of SIM restricted its application as a chemotherapy agent …
The potential of isoprenoids in adjuvant cancer therapy to reduce adverse effects of statins
The mevalonate pathway provides sterols for membrane structure and nonsterol
intermediates for the post-translational modification and membrane anchorage of growth …
intermediates for the post-translational modification and membrane anchorage of growth …
Statins: Complex outcomes but increasingly helpful treatment options for patients
Statins are long known class of medicines and the most frequently prescribed drugs in
cardiovascular pharmacotherapy, widely ordered not only in patients suffering from …
cardiovascular pharmacotherapy, widely ordered not only in patients suffering from …
Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma
SL Haney, D Feng, YS Chhonker… - Drug development …, 2023 - Wiley Online Library
Rab GTPases are critical regulators of protein trafficking in the cell. To ensure proper cellular
localization and function, Rab proteins must undergo a posttranslational modification …
localization and function, Rab proteins must undergo a posttranslational modification …
Suppression of MET signaling mediated by pitavastatin and capmatinib inhibits oral and esophageal cancer cell growth
B Xu, T Muramatsu, J Inazawa - Molecular Cancer Research, 2021 - AACR
Despite increasing knowledge on oral and esophageal squamous cell carcinoma (OSCC
and ESCC), specific medicines against both have not yet been developed. Here, we aimed …
and ESCC), specific medicines against both have not yet been developed. Here, we aimed …